The Impact of Medication on Health-Related Quality of Life in Patients with Generalized Anxiety Disorder
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Impact of Medication on Health-Related Quality of Life in Patients with Generalized Anxiety Disorder
Authors
Keywords
Generalize Anxiety Disorder, Work Productivity, Duloxetine, Escitalopram, Physical Component Summary Score
Journal
CNS DRUGS
Volume 29, Issue 1, Pages 29-40
Publisher
Springer Nature
Online
2014-12-16
DOI
10.1007/s40263-014-0217-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder
- (2014) Atul R. Mahableshwarkar et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Lavender oil preparation Silexan is effective in generalized anxiety disorder – a randomized, double-blind comparison to placebo and paroxetine
- (2014) Siegfried Kasper et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Vortioxetine (Lu AA21004) in generalized anxiety disorder: Results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial
- (2012) Leszek Bidzan et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder
- (2012) Irina Mezhebovsky et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder
- (2012) Jean Endicott et al. Neuropsychiatric Disease and Treatment
- Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder
- (2011) Charles Merideth et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Humanistic and economic burden of generalized anxiety disorder in North America and Europe
- (2011) Dennis A. Revicki et al. JOURNAL OF AFFECTIVE DISORDERS
- A Randomized, Double-Blind Study of Once-Daily Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients With Generalized Anxiety Disorder
- (2011) Arifulla Khan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder
- (2010) Martin A. Katzman et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Understanding the relationships between health outcomes in generalized anxiety disorder clinical trials
- (2010) Kathleen W. Wyrwich et al. QUALITY OF LIFE RESEARCH
- Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder
- (2009) Basil G. Bereza et al. CLINICAL THERAPEUTICS
- Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder
- (2009) Koen Demyttenaere et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Assessing health-related quality of life in generalized anxiety disorder using the Quality Of Life Enjoyment and Satisfaction Questionnaire
- (2009) Kathleen Wyrwich et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study
- (2009) Borwin Bandelow et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder
- (2009) H. Woelk et al. PHYTOMEDICINE
- The relationship between functional outcomes and the treatment of anxious and painful somatic symptoms in patients with generalized anxiety disorder
- (2008) David V. Sheehan et al. CURRENT MEDICAL RESEARCH AND OPINION
- Health-related quality of life and utilities in primary-care patients with generalized anxiety disorder
- (2008) Dennis A. Revicki et al. QUALITY OF LIFE RESEARCH
- Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder
- (2007) Anjana Bose et al. DEPRESSION AND ANXIETY
- Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial
- (2007) Moira Rynn et al. DEPRESSION AND ANXIETY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now